Skip to main content Skip to main navigation menu Skip to site footer
International Journal of Current Research in Physiology and Pharmacology
Short Communication
Submitted: 2023-08-10
Published: 2023-09-30

Epilepsy and Neuroinflammation: Unraveling the Complex Connection

Department of Pharmacology, CT Institute of Pharmaceutical Sciences, PTU, Jalandhar Punjab, India.
Department of Pharmacology, CT Institute of Pharmaceutical Sciences, PTU, Jalandhar Punjab, India.
Senior Resident, Department of Pharmacology, Government Medical College Baramulla, India.
Department of Pharmacology, CT Institute of Pharmaceutical Sciences, PTU, Jalandhar Punjab, India.
Epilepsy, neuroinflammation, seizures, inflammation.

Abstract

ABSTRACT

Epilepsy, a neurological disorder characterized by recurring seizures, has long been a subject of scientific exploration. Recent research has unveiled an intriguing link between epilepsy and neuroinflammation, the brain's immune response to injury or infection. This connection has shed light on how inflammation contributes to the development and progression of epilepsy. Neuroinflammation appears to play a pivotal role in epileptogenesis—the process of normal brain tissue becoming hyperexcitable and prone to seizures. Immune cells like microglia and astrocytes release inflammatory molecules that disrupt neurotransmitter balance, promoting neuronal hyperexcitability. This heightened excitability sets the stage for seizure generation. The interaction between neuroinflammation and seizures is bidirectional. Seizures can trigger immune responses, releasing pro-inflammatory molecules. Conversely, inflammation lowers the seizure threshold, making individuals more susceptible to seizures. Mechanisms underlying this relationship include blood-brain barrier dysfunction, altered synaptic plasticity, and an imbalance between excitatory and inhibitory signaling. Understanding these mechanisms has therapeutic implications. Targeting neuroinflammatory pathways could suppress inflammation and reduce seizure frequency. Neuroprotective agents may prevent inflammation-induced damage and halt epileptogenesis. Immunomodulatory treatments might restore the balance between pro- and anti-inflammatory responses, regulating neuroinflammation and reducing seizure susceptibility. The intricate interplay between epilepsy and neuroinflammation is a captivating field of study. Unraveling this complex connection offers insights into the underlying mechanisms of epilepsy, potentially leading to novel therapeutic approaches. By addressing both neurological and inflammatory aspects, researchers aim to improve epilepsy management and enhance the lives of those affected by this condition.

Keywords: Epilepsy, neuroinflammation, seizures, inflammation.

References

  1. M. Maqbool, F. Bekele, G.J.B.C.T. Fekadu, Therapy, Treatment strategies against triple-negative breast cancer: an updated review, (2022) 15-24.
  2. A.S. Galanopoulou, P.S. Buckmaster, K.J. Staley, S.L. Moshé, E. Perucca, J. Engel Jr, W. Löscher, J.L. Noebels, A. Pitkänen, J.J.E. Stables, Identification of new epilepsy treatments: issues in preclinical methodology, 53(3) (2012) 571-582.
  3. R. Maqbool, M. Maqbool, M. Zehravi, I.J.I.j.o.a.m. Ara, health, Menstrual distress in females of reproductive age: a literature review, 34(2) (2021) 11-17.
  4. E.J.N. Beghi, The epidemiology of epilepsy, 54(2) (2020) 185-191.
  5. M. Maqbool, G. Fekadu, X. Jiang, F. Bekele, T. Tolossa, E. Turi, G. Fetensa, K.J.A.o.M. Fanta, Surgery, An up to date on clinical prospects and management of osteoarthritis, 72 (2021) 103077.
  6. M. Zehravi, M. Maqbool, I.J.I.J.o.A.M. Ara, Health, Correlation between obesity, gestational diabetes mellitus, and pregnancy outcomes: an overview, 33(6) (2021) 339-345.
  7. S.L. Moshé, E. Perucca, P. Ryvlin, T.J.T.L. Tomson, Epilepsy: new advances, 385(9971) (2015) 884-898.
  8. M. Zehravi, M. Maqbool, I.J.I.J.o.A.M. Ara, Health, Depression and anxiety in women with polycystic ovarian syndrome: a literature survey, 33(6) (2021) 367-373.
  9. R.D. Thijs, R. Surges, T.J. O'Brien, J.W.J.T.L. Sander, Epilepsy in adults, 393(10172) (2019) 689-701.
  10. M. Zehravi, M. Maqbool, I.J.I.j.o.a.m. Ara, health, Polycystic ovary syndrome and reproductive health of women: a curious association, 33(6) (2021) 333-337.
  11. M. Zehravi, M. Maqbool, I.J.O.H. Ara, Healthy lifestyle and dietary approaches to treating polycystic ovary syndrome: a review, 3(1) (2022) 60-65.
  12. R.F. Tuchman, I. Rapin, S.J.P. Shinnar, Autistic and dysphasic children. II: Epilepsy, 88(6) (1991) 1219-1225.
  13. M. Zehravi, M. Maqbool, I.J.I.J.o.A.M. Ara, Health, Teenage menstrual dysfunction: an overview, 35(1) (2022) 15-19.
  14. M. Maqbool, I. Gani, M.A.J.A.J.o.P.R. Dar, Development, Anti-diabetic effects of some medicinal plants in experimental animals: a review, 7(1) (2019) 66-69.
  15. I. Ara, M. Maqbool, I.J.I.J.o.C.R.i.P. Gani, Pharmacology, Reproductive Health of Women: implications and attributes, (2022) 8-18.
  16. R. Bashir, M. Maqbool, I. Ara, M.J.C. Zehravi, An In sight into Novel Drug Delivery System: In Situ Gels, 11(1) (2021) 6.1-6.7.
  17. M. Maqbool, G. Fekadu, D. Dugassa, F. Bekele, E. Turi, D.J.A.o.N. Simegnew, The pattern of substance abuse in the psychiatry department of a tertiary care of Srinagar hospital, Jammu and Kashmir, India, 7(4) (2020).
  18. I. Ara, M. Zehravi, M. Maqbool, I.J.J.o.P.R. Gani, R.S.J.-D.d. org/10.47363/JPRSR/, A review of recent developments and future challenges in the implementation of universal health coverage policy framework in some countries, 127 (2022).
  19. M. Maqbool, M. Zehravi, R. Maqbool, I.J.C. Ara, An overview about treatment of gestational diabetes mellitus: A short communication, 11(3) (2021) 12.1-12.5.
  20. M. Zehravi, M. Maqbool, I.J.I.J.o.A.M. Ara, Health, Unfolding the mystery of premenstrual syndrome (PMS): an overview, 35(1) (2022) 9-13.
  21. I. Ara, M. Maqbool, B. Bukhari, N. Ara, T.A.J.I.J.o.R.i.P.S. Hajam, Technology, Present status, standardization and safety issues with herbal drugs, 1(3) (2020) 95-101.
  22. I. Ara, M. Maqbool, I.J.I.J.o.C.R.i.P. Gani, Pharmacology, Neuroprotective Activity of Herbal Medicinal Products: A Review, (2022) 1-10.
  23. M. Maqbool, M.J.I.P.M. Zehravi, Neuromodulation, Neuroprotective role of polyphenols in treatment of neurological disorders: A review, 1(1) (2021).
  24. I. Ara, M.J.O.H. Maqbool, The curious case of Neuropathic Pain and its management: an overview, 3(1) (2022) 145-154.
  25. I. Ara, M. Maqbool, G. Fekadu, T.A. Hajam, M.A.J.J.o.A.P.S. Dar, Research, Pharmaceutical significance of Nigella sativa L., a wonder herb, 3(4) (2020) 04-13.
  26. M. Zehravi, M. Maqbool, I.J.T.I.J.o.N. Ara, Dietetics, An Update on Pain Control in Conservative Dentistry and Endodontics: A Review, (2022) 114-125.
  27. R. Maqbool, M. Maqbool, M. Zehravi, I.J.I.J.o.A.M. Ara, Health, Acute neurological conditions during pregnancy and their management: a review, 33(6) (2021) 357-366.
  28. M. Maqbool, M. Zehravi, R. Maqbool, I.J.C. Ara, Study of adverse drug reactions in pulmonary medicine department of a Tertiary care hospital, Srinagar, Jammu & Kashmir, India, 11(2) (2021) 8.1-8.5.
  29. M. Zehravi, R. Maqbool, M. Maqbool, I.J.J.o.P.R.I. Ara, To Identify Patterns of Drug Usage among Patients Who Seek Care in Psychiatry Outpatient Department of a Tertiary Care Hospital in Srinagar, Jammu and Kashmir, India, 33(31A) (2021) 135-140.
  30. M.J.J.o.A.P.S. Maqbool, Research, Evaluation of drug utilization pattern in the pediatric department of a Tertiary Care Hospital in Srinagar, Jammu & Kashmir, India, (2019) 6-9.
  31. M. Maqbool, I.J.J.o.P.P. Gani, C. Medicine, Utilization of statins in reducing comorbidities of diabetes mellitus: A systematic review, 4(4) (2018).
  32. G. Fekadu, B. Gamachu, T. Mengie, M.J.I.J. Maqbool, Knowledge, attitude of health care professional’s towards clinical pharmacy services in Nedjo General Hospital, Western Ethiopia, 5(7) (2019) 172.
  33. I. Ara, M. Maqbool, I.J.I.J.o.C.R.i.P. Gani, Pharmacology, Specificity and Personalized medicine: a novel approach to Cancer management, (2022) 11-20.
  34. I. Ara, M. Maqbool, I.J.C.H.C.M.J. Gani, Role of Insulin Resistance in Gestational Diabetes Mellitus: A Literature Review, 11(2) (2022) 69-74.
  35. M.A. Dar, M. Maqbool, I. Gani, I.J.I.J.o.C.R.i.P. Ara, Pharmacology, Menstruation hygiene and related issues in adolescent girls: A brief commentary, (2023) 1-5.
  36. M. Maqbool, M.J.P. Khan, Hypertension and Pregnancy: an important issue, 7(8) (2019) 71-78.
  37. I. Ara, M. Maqbool, M. Zehravi, I.J.A.J.C.B. Gani, Herbs Boosting Immunity in Covid-19: An Overview, 3(3) (2020) 289-94.
  38. M. Zehravi, M. Maqbool, I.J.T.I.J.o.N. Ara, Dietetics, An overview about safety surveillance of adverse drug reactions and pharmacovigilance in India, (2021) 408-418.
  39. M. Maqbool, I. Ara, I.J.I.J.o.C.R.i.P. Gani, Pharmacology, The Story of Polycystic Ovarian Syndrome: A Challenging Disorder with Numerous Consequences for Females of Reproductive Age, (2022) 19-31.
  40. R. Bashir, M. Maqbool, M. Zehravi, I.J.A.J.C.S.B. Ara, Utilization of herbal cosmetics: A brief overview, 3 (2021) 277-288.
  41. M. Maqbool, M.A. Dar, S. Rasool, A.U. Bhat, M.I.J.J.o.D.D. Geer, Therapeutics, Drug safety and Pharmacovigilance: An overview, 9(2-s) (2019) 543-548.
  42. M. Maqbool, M.A. Dar, S. Rasool, I. Gani, M.I.J.R.J.o.P. Geer, Technology, Universal health coverage policy and practice framework in India: a review, 12(8) (2019) 4045-4051.
  43. M.A. Dar, M. Maqbool, I.J.J.o.E.o.M. Ara, D. Sciences, Metformin and Other Sulfonylureas for Glycemic Control in Type 2 Diabetic Patients at a Tertiary Care Hospital in Jammu & Kashmir, (2023) 197-201.
  44. M.A. Dar, M. Maqbool, I.J.J.o.E.o.M. Ara, D. Sciences, Patterns of Drug Use in Geriatric Patients at a Tertiary Care Teaching Hospital in Jammu and Kashmir, (2023) 182-186.
  45. M.A. Dar, M. Maqbool, I.J.J.o.E.o.M. Ara, D. Sciences, Prescription Pattern of Antibiotics in Pulmonary Ward of a Tertiary Care Hospital, Jammu and Kashmir, (2023) 171-175.
  46. M.M. Willie, M.J.A.S.R.P. Maqbool, Access to public health services in South Africa’s rural Eastern Cape Province, 1(2) (2023) 35-54.
  47. M. Maqbool, N. Nasir, S.J.I.A.J.O.P.S. Mustafa, Polycystic in ovarian syndrome and its various treatment strategies, 5(9) (2018) 8470-8478.

How to Cite

Mashooq Ahmad Mir, Bashir Malik, A., Qadrie, Z., & Altaf Dar, M. (2023). Epilepsy and Neuroinflammation: Unraveling the Complex Connection. International Journal of Current Research in Physiology and Pharmacology, 3–9. Retrieved from https://ijcrpp.com/index.php/ijcrpp/article/view/80